|Articles|January 15, 2013
- The Column-01-15-2013
- Volume 9
- Issue 1
Characterization of Antibody-Drug Conjugates by SEC with Combined Light Scattering, dRI and UV Detection
There has been a significant resurgence in the development of antibody-drug conjugates (ADC) as target-specific therapeutic agents for cancer treatments. This article presents a method for DAR determination based on size-exclusion chromatography with multi-angle light scattering (SEC?MALS) combined with ultraviolet (UV) absorption and differential refractive index (dRI) detection.
Advertisement
There has been a significant resurgence in the development of antibody‑drug conjugates (ADC) as target-specific therapeutic agents for cancer treatments. A critical factor for ADC formulations is the drug‑to‑antibody ratio (DAR), which describes the degree of modification. This article presents a method for DAR determination based on size-exclusion chromatography with multi-angle light scattering (SEC–MALS) combined with ultraviolet (UV) absorption and differential refractive index (dRI) detection.
Articles in this issue
over 13 years ago
Bugs boost wine aromaover 13 years ago
The Elephant in the Roomover 13 years ago
EDCs alter US water qualityAdvertisement
Related Content
Advertisement
Best of the Week: Separation Science Across Food Safety and Human Health
Published: | Updated:
Advertisement
Advertisement